Shaping the future of animal health
Virbac group
Finance contact
Investor Relations
Virbac
13e rue LID - BP 27
F 06511 Carros cedex
Fax: +33 4 92 08 76 58
 

Public releases 2014

2014 annual results

Monday, March 16, 2015 

Public release

 

Results grow in 2014 following a strong second half

Read more

2014 Annual consolidated sales

Thursday, January 15, 2015 

Public release

 

Sustained growth in the fourth quarter

Read more

Virbac agrees to acquire veterinary assets from Eli Lilly in the United States

Monday, October 27, 2014 

Public release

Virbac announces that it has entered into an agreement with Eli Lilly and Company to acquire major United States veterinary products currently marketed by Novartis Animal Health. Eli Lilly has agreed to divest these U.S. assets in connection with the U.S. Federal Trade Commission’s review of Eli Lilly’s pending acquisition of Novartis Animal Health worldwide.

Read more

2014 third quarter consolidated sales

Thursday, October 16, 2014 

Public release

Confirmation of the rebound of growth in the third quarter

Read more

2014 half year results

Friday, August 29, 2014 

Public release

Half-year results impacted by foreign exchange and the low level of activity in the United States

Read more

Share on Facebook Share on Google Print current page